Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
Oncology
1 drug in development·1 company·1 clinical trial
Drug Pipeline by Phase
Phase 3(1)
| Drug | Company |
|---|---|
| Sonrotoclax | ENANTA PHARMACEUTICALS INC (ENTA) |
Frequently asked questions
How many drugs are in development for Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma?
BioSniper tracks 1 drug in development for Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma across 1 company.
How many clinical trials target Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma?
There are 1 clinical trial targeting Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma tracked by BioSniper.
Deep-dive into Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis